While drugs are on the market to slow the progression of neurodegenerative diseases, there are still no cures. But researchers are looking for new pathways for slowing neuronal dysfunction and treating amyotrophic lateral sclerosis (ALS), a fatal motor neuron disease. The team found that proteins involved in the innate immune system could be at the root of the disease.
“The unmet need for therapies for neurodegenerative diseases is huge, and our work opens up a whole new pathology that we could address,” says a researcher.
“We revealed an innate immune molecule playing a role in neurodegeneration, which opens up a new avenue for thinking about neuronal health,” says a co-principal investigator on the project.
The researchers found that inactivating a molecule in the brain linked with inflammation prevents cellular damage in human neurons and delays the progression of ALS in mice. The findings will be published in Neuron .
When cells recognize danger, like an infection, immune molecules are activated to sound an alarm that recruits and activates immune cells to the site of damage to try to eliminate it and orchestrate tissue repair. Sometimes, the immune response involves a family of proteins called gasdermins, which trigger cells to die through a highly inflammatory process called pyroptosis. One type of gasdermin, gasdermin E, is expressed in the brain most highly in nerve cells. But no one knew what it’s doing.
The research team first examined how gasdermin E affects neurons. The team developed models of neurons from mice and from human samples and looked at the effects of gasdermin E on axons, or the parts of neurons that send electrical signals. The researchers found that when neurons detect a hazard, gasdermin E drives damage to the powerhouse of the cell, known as mitochondria, and the axons. The axons degenerate, but the cells don’t die.
“If you look at a plate of neurons, you see a jungle of axons. But if you look at a plate where gasdermin E is activated, you see retractions of these cellular processes,” explains the study lead. This retraction happens in nerves in the muscles of patients with ALS, a progressive disease characterized by muscle twitching and weakness, but eventually progressing to muscle atrophy and paralysis.
“Our study is an example of how immunology can help explain neurodegeneration on a mechanistic level, and what drives axon loss and neuronal injury,” says the other co-lead.
To better understand the relationship between gasdermin E and neurodegeneration, the team created models of ALS motor neurons by transforming stem cell samples of ALS patients into neurons. The researchers found that gasdermin E is present at high levels in these neurons. And they could protect axons and mitochondria from damage by silencing gasdermin E.
The team then wanted to test whether the effects they saw in cells could translate to improvements in symptoms related to neurodegeneration. The researchers silenced gasdermin E in a mouse model of ALS. They found that it delayed the progression of symptoms and led to protected motor neurons, longer axons, and less overall inflammation. These findings suggest that gasdermin E drives changes to neurons that may contribute to disease progression. “Inflammation is a double-edged sword, and could be very destructive based on context,” says the author.
Though some drugs can block the effects of other gasdermins, it is still unclear whether gasdermin E can be targeted with drugs. But this work is an important first step towards developing new approaches for treating ALS. “We describe a pathway and molecules that you can target for treating many neurodegenerative diseases,” says the author.
https://www.cell.com/neuron/fulltext/S0896-6273(23)00123-X
The role of innate immune system in neurodegeneration
- 911 views
- Added
Latest News
New origin of deep brain waves
By newseditor
Posted 17 Apr
Starving cells hijack prote…
By newseditor
Posted 17 Apr
Miniature battery-free epid…
By newseditor
Posted 17 Apr
Molecular causes of differe…
By newseditor
Posted 16 Apr
Cell's 'garbage disposal' h…
By newseditor
Posted 16 Apr
Other Top Stories
Pro inflammatory molecule modulates brain function
Read more
Antibodies as 'messengers' in the nervous system
Read more
Microbiota-initiated antibody formation in mice
Read more
Universal immune mechanism as a regulator of sleep
Read more
Monoclonal antibody given to preterm babies may reduce wheeze later
Read more
Protocols
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Modular dual-color BiAD sen…
By newseditor
Posted 31 Mar
Publications
The immunobiology of herpes…
By newseditor
Posted 17 Apr
Circulating microbiome DNA…
By newseditor
Posted 17 Apr
Spindle oscillations in com…
By newseditor
Posted 17 Apr
Oligodendroglial macroautop…
By newseditor
Posted 17 Apr
COPII with ALG2 and ESCRTs…
By newseditor
Posted 17 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar